Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2022. Start Trial.
Date Value
November 19, 2026 1.179M
November 18, 2026 1.298M
November 17, 2026 1.357M
November 16, 2026 1.594M
November 13, 2026 1.890M
November 12, 2026 1.830M
November 11, 2026 1.978M
November 10, 2026 1.801M
November 09, 2026 1.682M
November 06, 2026 1.182M
November 05, 2026 1.253M
November 04, 2026 1.164M
November 03, 2026 1.031M
November 02, 2026 1.238M
October 30, 2026 1.238M
October 29, 2026 1.475M
October 28, 2026 1.327M
October 27, 2026 1.327M
October 26, 2026 1.386M
October 23, 2026 1.298M
October 22, 2026 1.342M
October 21, 2026 1.534M
October 20, 2026 1.386M
October 19, 2026 1.150M
October 16, 2026 1.298M
Date Value
October 15, 2026 1.505M
October 14, 2026 1.238M
October 13, 2026 1.475M
October 12, 2026 1.564M
October 09, 2026 1.830M
October 08, 2026 1.801M
October 07, 2026 2.097M
October 06, 2026 2.215M
October 05, 2026 2.393M
October 02, 2026 2.097M
October 01, 2026 1.978M
September 30, 2026 1.919M
September 29, 2026 0.3173M
September 28, 2026 0.3877M
September 25, 2026 0.554M
September 24, 2026 0.4356M
September 23, 2026 0.4652M
September 22, 2026 0.4652M
September 21, 2026 0.4652M
September 18, 2026 0.7612M
September 17, 2026 0.7908M
September 16, 2026 0.702M
September 15, 2026 0.702M
September 14, 2026 0.9092M
September 11, 2026 0.7908M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Tenax Therapeutics, Inc. -50.43M
Exicure, Inc. 4.529M
Century Therapeutics, Inc. 159.53M
Absci Corp. 1.236B
Celularity, Inc. 82.95M